All the funding deals in the mental health market
Last updated: 13 July 2026
Download our beautiful pitch about the mental health market
In our mental health market deck, you will find everything you need to understand the market
The mental health market is attracting funding across care delivery, clinical software, diagnostics, medical devices, and new medicines.
We conducted deep research and collected 73 mental health market funding deals announced from Q1 2024 through Q2 2026.
We refresh this page very often to add newly announced mental health funding deals.
And if you want to better understand this new industry, you should get our beautiful slides covering the mental health market.
Insights
- The 73 mental health market deals raised about $2.72 billion in total. The disclosed annual total increased from $829 million in 2024 to $1.13 billion in 2025.
- Drug developers received several of the largest mental health funding rounds. MapLight Therapeutics, Syremis Therapeutics, Draig Therapeutics, and Newleos Therapeutics raised $771 million combined.
- Talkiatry and Grow Therapy raised $360 million in Q1 2026. Both companies are expanding insurance-supported access to mental health clinicians.
- Youth mental health remained a major funding theme. At least 15 deals focused mainly on children, teenagers, students, young adults, or families.
- Substance-use treatment companies continued to attract capital. The funded companies address alcohol, opioids, tobacco, nicotine, and related mental health conditions.
- Artificial intelligence became more visible in the mental health market. Funded companies use AI for clinical documentation, patient support, diagnosis, triage, and clinic administration.
- The mental health market includes both care providers and enabling software. Investors funded therapy networks, psychiatric clinics, school platforms, operating systems, and clinical workflow tools.
- Several companies raised capital more than once during the period. Amae Health, Grow Therapy, InStride Health, Jimini Health, Seven Starling, TadHealth, and Tava Health returned with new rounds.
- Women’s mental health gained dedicated investment through Seven Starling and FamilyWell Health, which focus on pregnancy, postpartum care, fertility, menopause, and related needs.
- Advanced psychiatric treatments are becoming a distinct funding category. Investors backed ketamine care, TMS systems, Spravato services, clozapine therapies, and MDMA-assisted treatment development.
This chart, featured in our mental health market deck, illustrates yearly VC investment in mental health startups
Summary table of the funding deals for the mental health market since 2024
We define the mental health market as the set of services and products that diagnose, treat, or clinically manage mental and substance use disorders.
We include licensed providers, facilities, medications, and clinically validated digital tools that are used to assess or treat recognized mental and substance use conditions.
We exclude general wellness, self-help, fitness, and lifestyle products that aim to improve mood or wellbeing but are not used as formal clinical treatment.
We focused exclusively on pure players, defined as companies with at least 70–80% of their business directly tied to the mental health market.
Our analysis has been done at a global level with a minimum funding threshold of $300k.
You can also read our detailed analysis to understand how funding activity in the mental health market has evolved recently.
If you want a longer-term view, we also have a study of how funding activity in the mental health market has changed over the years.
Also, you should know that we have a dedicated page, updated weekly, with all the latest fundraising deals in the mental health market.
| Name | What they do | Amount in $ | Quarter | Source(s) |
|---|---|---|---|---|
| InStride Health | Provides insurance-covered virtual treatment for young people with anxiety and OCD | $30.0M | Q2 2026 | Fierce Healthcare |
| Radley Health | Provides peer-supported care for adults living with serious mental illness | $3.0M | Q2 2026 | PR Newswire |
| The Path | Provides AI-supported therapy with crisis detection and access to human therapists | $14.3M | Q2 2026 | HIT Consultant |
| Ampa | Develops a portable magnetic brain-stimulation system for depression treatment | ~$17.0M | Q2 2026 | PR Newswire |
| Tava Health | Provides therapy access and technology tools for mental health clinicians | $40.0M | Q2 2026 | Behavioral Health Business |
| Trayt Health | Helps providers screen patients, coordinate referrals, and track behavioral health care | $7.17M | Q2 2026 | FormDs |
| Jimini Health | Provides supervised AI tools for behavioral health providers and their patients | $17.0M | Q1 2026 | Jimini Health |
| Blossom Health | Combines psychiatrists with AI tools for clinical and administrative work | $20.0M | Q1 2026 | PR Newswire |
| Gilgamesh Pharma | Develops new medicines for depression and other psychiatric conditions | $60.0M | Q1 2026 | PR Newswire |
| Amani Therapeutics | Develops a clozapine-based treatment for treatment-resistant schizophrenia | $25.0M | Q1 2026 | Business Wire |
| Grow Therapy | Helps therapists provide insurance-covered online and in-person mental health care | $150.0M | Q1 2026 | PR Newswire |
| Ease Health | Provides clinical, billing, and customer-management software for behavioral health providers | $41.0M | Q1 2026 | Business Wire |
| Salma Health | Combines psychiatry, neurology, diagnostics, and AI-supported brain health care | $80.0M | Q1 2026 | Salma Health |
| Big Health | Develops regulated digital treatments for insomnia and anxiety disorders | $23.7M | Q1 2026 | Big Health |
| Talkiatry | Provides insurance-covered virtual psychiatry and therapy with employed clinicians | $210.0M | Q1 2026 | WSJ |
| Somethings | Connects teenagers and young adults with trained mental health mentors | $19.2M | Q1 2026 | PR Newswire |
| Oasys Health | Provides management, billing, and clinical software for behavioral health clinics | $4.6M | Q1 2026 | PR Newswire |
| Syremis Therapeutics | Develops medicines for schizophrenia, depression, and bipolar disorder | $165.0M | Q4 2025 | Business Wire |
| Circular Genomics | Develops RNA-based diagnostic and treatment-selection tools for mental health conditions | $15.0M | Q4 2025 | Circular Genomics |
| Radial | Operates psychiatric clinics offering TMS, Spravato, and other advanced treatments | $50.0M | Q4 2025 | Behavioral Health Business |
| FamilyWell Health | Provides mental health care within women's health practices | $8.0M | Q4 2025 | HIT Consultant |
| Amae Health | Provides coordinated outpatient care for people with serious mental illness | $25.0M | Q4 2025 | Business Wire |
| Marble Health | Connects students with licensed mental health therapists through schools | $15.5M | Q4 2025 | PR Newswire |
| Triplemoon | Provides virtual pediatric mental health care through primary care clinics | $3.5M | Q4 2025 | Business Wire |
| Everbright Health | Helps providers offer TMS, Spravato, and other advanced psychiatric treatments | $7.0M | Q4 2025 | PR Newswire |
| Allswell | Matches LGBTQ+ patients with therapists trained for their mental health needs | $1.3M | Q4 2025 | Fierce Healthcare |
| Cerebral | Provides virtual therapy and psychiatric medication management | $25.0M | Q3 2025 | Behavioral Health Business |
| Affect Therapeutics | Provides virtual treatment for substance use and related mental health conditions | $26.0M | Q3 2025 | Affect Therapeutics |
| Seven Starling | Provides virtual mental health care for women and new parents | $8.0M | Q3 2025 | Access Newswire |
| Cartwheel Care | Provides therapy, psychiatry, and family support through school partnerships | $35.17M | Q3 2025 | Behavioral Health Business |
| MapLight Therapeutics | Develops medicines for schizophrenia and other neuropsychiatric conditions | $372.5M | Q3 2025 | MapLight Therapeutics |
| Clearly | Combines licensed therapists, video sessions, and AI-supported mental health care | $1.35M | Q3 2025 | Vestbee |
| Handspring Health | Provides virtual therapy for young people and their families | $12.0M | Q2 2025 | PR Newswire |
| Draig Therapeutics | Develops medicines for depression and other neuropsychiatric disorders | $140.0M | Q2 2025 | BioSpace |
| Mentaily | Develops AI tools for mental health assessment, diagnosis, and triage | $3.0M | Q2 2025 | EIN Presswire |
| Noma Therapy | Provides insurance-covered virtual ketamine therapy and medication management | $4.25M | Q2 2025 | PRWeb |
| TadHealth | Provides mental health technology and support services for schools | $5.5M | Q2 2025 | Business Wire |
| Jones / HC Jones | Combines nicotine replacement products with app-based quitting support | $9.0M | Q2 2025 | Behavioral Health Business |
| Ria Health | Provides telehealth treatment for alcohol-use disorder | $12.5M | Q1 2025 | Behavioral Health Business |
| Sonar Mental Health | Provides AI-supported mental health assistance for students and schools | $2.4M | Q1 2025 | PR Newswire |
| Newleos Therapeutics | Develops medicines for anxiety, addiction, and cognitive impairment | $93.5M | Q1 2025 | Business Wire |
| Little Otter | Provides digital mental health care for children, parents, and families | $9.5M | Q1 2025 | Business Wire |
| Bicycle Health | Provides virtual medication-supported treatment for opioid-use disorder | $16.5M | Q1 2025 | MobiHealthNews |
| Eleos Health | Provides AI documentation and care tools for behavioral health clinicians | $60.0M | Q1 2025 | HIT Consultant |
| Anise Health | Provides culturally responsive digital mental health care for Asian Americans | $3.0M | Q4 2024 | Axios |
| Fort Health | Provides virtual pediatric mental health care through doctors and insurers | $5.5M | Q4 2024 | PR Newswire |
| Jimini Health | Combines licensed mental health clinicians with supervised AI support | $8.0M | Q4 2024 | Behavioral Health Business |
| Nema Health | Provides virtual therapy, medication, and peer support for trauma and PTSD | $14.0M | Q4 2024 | Behavioral Health Business |
| BeMe Health | Provides digital behavioral health support for teenagers | $12.5M | Q3 2024 | Business Wire |
| Neurode | Develops a wearable headband for ADHD treatment and monitoring | $3.5M | Q3 2024 | Startup Daily |
| Spring Health | Provides mental health care through employers and health plans | $100.0M | Q3 2024 | PR Newswire |
| Headway | Helps patients find insured therapists and helps clinicians accept insurance | $100.0M | Q3 2024 | PR Newswire |
| Seven Starling | Provides virtual mental health care for women and new mothers | $10.9M | Q3 2024 | Access Newswire |
| Meela | Matches patients with therapists suited to their mental health needs | $2.8M | Q3 2024 | Peak Capital |
| Marigold Health | Provides peer recovery support for people with substance-use disorder | $11.0M | Q2 2024 | Business Wire |
| TadHealth | Provides mental health technology and services for schools | $1.6M | Q2 2024 | Business Wire |
| Boulder Care | Provides app-based treatment for opioid and alcohol-use disorders | $35.0M | Q2 2024 | GeekWire |
| Backpack Healthcare | Provides online mental health care and therapy for children | $14.0M | Q2 2024 | PR Newswire |
| Amae Health | Provides psychiatry-led outpatient care for serious mental illness | $15.0M | Q2 2024 | PR Newswire |
| Clarity Pediatrics | Provides virtual ADHD care for children and their families | $10.0M | Q2 2024 | Business Wire |
| Two Chairs | Offers online and in-person therapy with personalized therapist matching | $72.0M | Q2 2024 | TechCrunch |
| Grow Therapy | Helps therapists provide insurance-covered online and in-person mental health care | $88.0M | Q2 2024 | PR Newswire |
| Pelago | Provides digital treatment for tobacco, alcohol, and opioid-use disorders | $58.0M | Q1 2024 | Pelago |
| InStride Health | Provides outpatient treatment for young people with anxiety and OCD | $30.0M | Q1 2024 | InStride Health |
| Brightside Health | Provides online therapy and psychiatry for mood and anxiety disorders | $33.0M | Q1 2024 | Business Wire |
| Tava Health | Connects employees and health plan members with mental health therapists | $20.0M | Q1 2024 | PR Newswire |
| Limbic | Develops AI tools for mental health assessment, triage, and support | $14.0M | Q1 2024 | Business Wire |
| Blackbird Health | Provides integrated mental health care for children and young adults | $17.0M | Q1 2024 | PR Newswire |
| Headlight | Offers online and in-person therapy and psychiatric care | $18.0M | Q1 2024 | PR Newswire |
| Being Health | Combines psychiatry, therapy, ketamine treatment, and related clinical services | $5.4M | Q1 2024 | Business Wire |
| Amaha | Provides care for anxiety, depression, ADHD, OCD, and related conditions | $4.4M | Q1 2024 | Entrackr |
| Vita Health | Provides virtual suicide-prevention care, therapy, and psychiatry | $22.5M | Q1 2024 | MobiHealthNews |
| Lykos Therapeutics | Develops MDMA-assisted treatment for PTSD and other mental health conditions | $100.0M | Q1 2024 | Lykos Therapeutics |
This market map, featured in our mental health market deck, highlights top companies and startups in the mental health market
Related blog posts
- What is new in the mental health market lately?
- The most important recent news in the mental health market
- How big is the mental health market really?
- The most recent funding news in the mental health market
- The main fundraising trends in the mental health market
- The evolution of funding activity in the mental health market
